References,Sample size,Interventions,Main race,Female (%),Mean HAMA,Mean age (Year),Attrition rate (%),Sponsor,Follow-up time (weeks),Diagnosis criteria
"Rothschild et al., 2012",304,vortioxetine: 5 mg/day,"Caucasian (White, including Hispanic)",67.8,24.7,41.0,17.8,"Takeda Pharmaceutical Company, Ltd.",8,dsm-iv
"Rothschild et al., 2012",304,placebo,"Caucasian (White, including Hispanic)",63.8,24.6,41.4,25.0,"Takeda Pharmaceutical Company, Ltd.",8,dsm-iv
